Led by Dr Driton Vllasaliu from the Institute of Pharmaceutical Science, the NanoKos project, funded by EuropeAid, brings together King’s, the University of Prishtina (Kosovo), and partners at the University of Milan and University of Parma (Italy). Since 2022, this three-year initiative has focused on medical and environmental research, with a particular emphasis on nanoscience — a field that underpins both nanomedicine, for medical applications, and nanotoxicology, for studying environmental impact.
Creating lasting impact on researchers and research infrastructure
Through NanoKos, more than 30 Kosovo-based researchers and staff have completed internships and short placements at King’s and in Italy. These opportunities have given Kosovan researchers hands-on experience in advanced laboratory techniques and nanomaterials research, strengthening both their skills and their career prospects.
Other support provided through the project included enabling 40 staff visits and delivering 13 workshopsfor the purpose of knowledge exchange and training in specific research skills. Additionally, the project invested €180,000 in state-of-the-art nanomaterial characterisation and imaging equipment for the University of Prishtina, building important nanoscience-related laboratory infrastructure in Kosovo and delivering long-lasting impact. Training covered both practical experimental skills and broader topics such as grant funding. The project embedded a highly active public engagement campaign to raise the awareness of nanomedicine and nanotoxicology, focusing on educating the public on the harmful effects of air pollution (nanoparticulates).
Dr Vllasaliu, who is originally from Kosovo himself, described the enduring impact the project will have in Kosovo, at King’s, and the partner institutions.